| Date Initiated by Firm | July 02, 2012 |
| Date Posted | August 07, 2012 |
| Recall Status1 |
Terminated 3 on June 11, 2013 |
| Recall Number | Z-2154-2012 |
| Recall Event ID |
62595 |
| 510(K)Number | K971221 |
| Product Classification |
Tubes, vacuum sample, with anticoagulant - Product Code GIM
|
| Product | 3mL 9NC Coagulation Sodium Citrate 3.2%, Item #454334,
Greiner Bio-One North America Inc., 4238 Capital Drive, Monroe, NC 28110.
Intended Use: Venous blood collection tubes. |
| Code Information |
Lot #B041206 |
| FEI Number |
3001451379
|
Recalling Firm/ Manufacturer |
Greiner Bio-One North America, Inc. 4238 Capital Dr Monroe NC 28110
|
| For Additional Information Contact | Manfred Abel 704-261-7823 |
Manufacturer Reason for Recall | Part of the lot received a lower concentration of citrate solution which may cause falsely lower values for common coagulation tests. |
FDA Determined Cause 2 | Nonconforming Material/Component |
| Action | Distributors were notified by letter on 07/02/2012 and customers were sent a letter dated 07/05/2012. The letters identified the affected product and the reason for the recall. Distributors were asked to stop distributing the affected product and to complete the attached Product Disposition form. The form along with the affected product was to be returned to GBO. The firm will provide replacement stock or issue a credit once product return and receipt of the Product Disposition form has been confirmed. Customers were also asked to complete the Product Disposition Site Confirmation form and fax it back to Greiner Bio-One North America, Inc. at the number provided. The letter states that the firm will replace any affected product once the form is received. Questions should be directed to 800-515-8112. |
| Quantity in Commerce | 838.9 cases (1,006,700 pieces) |
| Distribution | Nationwide Distribution |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = GIM
|